Back to Search Start Over

SARS-CoV-2 Mutations and their Viral Variants.

Authors :
Cosar, Begum
Karagulleoglu, Zeynep Yagmur
Unal, Sinan
Ince, Ahmet Turan
Uncuoglu, Dilruba Beyza
Tuncer, Gizem
Kilinc, Bugrahan Regaip
Ozkan, Yunus Emre
Ozkoc, Hikmet Ceyda
Demir, Ibrahim Naki
Eker, Ali
Karagoz, Feyzanur
Simsek, Said Yasin
Yasar, Bunyamin
Pala, Mehmetcan
Demir, Aysegul
Atak, Irem Naz
Mendi, Aysegul Hanife
Bengi, Vahdi Umut
Cengiz Seval, Guldane
Source :
Cytokine & Growth Factor Reviews. Feb2022, Vol. 63, p10-22. 13p.
Publication Year :
2022

Abstract

• Mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus occur spontaneously during replication. • The fastest-spreading variants recently detected in the UK, South Africa and Brazil have been the focus of attention. • Mutations in glycoprotein S lead to vaccine escape as the situation is related to protein location and affinity. • The presence of the SARS-CoV-2 strains can be attributed to the heterogeneity of COVID-19 cases in different regions. Mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occur spontaneously during replication. Thousands of mutations have accumulated and continue to since the emergence of the virus. As novel mutations continue appearing at the scene, naturally, new variants are increasingly observed. Since the first occurrence of the SARS-CoV-2 infection, a wide variety of drug compounds affecting the binding sites of the virus have begun to be studied. As the drug and vaccine trials are continuing, it is of utmost importance to take into consideration the SARS-CoV-2 mutations and their respective frequencies since these data could lead the way to multi-drug combinations. The lack of effective therapeutic and preventive strategies against human coronaviruses (hCoVs) necessitates research that is of interest to the clinical applications. The reason why the mutations in glycoprotein S lead to vaccine escape is related to the location of the mutation and the affinity of the protein. At the same time, it can be said that variations should occur in areas such as the receptor-binding domain (RBD), and vaccines and antiviral drugs should be formulated by targeting more than one viral protein. In this review, a literature survey in the scope of the increasing SARS-CoV-2 mutations and the viral variations is conducted. In the light of current knowledge, the various disguises of the mutant SARS-CoV-2 forms and their apparent differences from the original strain are examined as they could possibly aid in finding the most appropriate therapeutic approaches. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13596101
Volume :
63
Database :
Academic Search Index
Journal :
Cytokine & Growth Factor Reviews
Publication Type :
Academic Journal
Accession number :
155527356
Full Text :
https://doi.org/10.1016/j.cytogfr.2021.06.001